Paragangliomas (PGLs) are catecholamine-secreting neoplasms of chromaffin cells and represent a rare but curable cause of secondary hypertension. Surgery is the treatment of choice for symptomatic PGLs. A small (7 mm) extra-adrenal PGL was diagnosed in the right retroperitoneal space in a 19-year-old patient affected by symptomatic hypertension unresponsive to medical treatment. Indication to percutaneous radiofrequency ablation (RFA) was given by a multidisciplinary team on the basis of the size of the nodule, the surgical risks, the young age of the patient, and his wish to reduce as much as possible the post-interventional rehabilitation. To our knowledge, the use of percutaneous RFA in the treatment of retroperitoneal extra-adrenal primary paragangliomas has never been described. We describe its feasibility and the patient’s clinical outcome.

Immediate Clinical Success After Percutaneous Ablation of Extra-adrenal Paraganglioma / A.M. Ierardi, P. Biondetti, G. Ferrante, S. Carugo, G. Carrafiello. - In: CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY. - ISSN 0174-1551. - 41:11(2018 Nov), pp. 1803-1806.

Immediate Clinical Success After Percutaneous Ablation of Extra-adrenal Paraganglioma

P. Biondetti
Secondo
;
G. Ferrante;S. Carugo
Penultimo
;
G. Carrafiello
Ultimo
2018

Abstract

Paragangliomas (PGLs) are catecholamine-secreting neoplasms of chromaffin cells and represent a rare but curable cause of secondary hypertension. Surgery is the treatment of choice for symptomatic PGLs. A small (7 mm) extra-adrenal PGL was diagnosed in the right retroperitoneal space in a 19-year-old patient affected by symptomatic hypertension unresponsive to medical treatment. Indication to percutaneous radiofrequency ablation (RFA) was given by a multidisciplinary team on the basis of the size of the nodule, the surgical risks, the young age of the patient, and his wish to reduce as much as possible the post-interventional rehabilitation. To our knowledge, the use of percutaneous RFA in the treatment of retroperitoneal extra-adrenal primary paragangliomas has never been described. We describe its feasibility and the patient’s clinical outcome.
Hypertension; Paraganglioma; Percutaneous radiofrequency ablation; Radiology, Nuclear Medicine and Imaging; Cardiology and Cardiovascular Medicine
Settore MED/36 - Diagnostica per Immagini e Radioterapia
nov-2018
Article (author)
File in questo prodotto:
File Dimensione Formato  
Ierardi2018_Article_ImmediateClinicalSuccessAfterP.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 722.62 kB
Formato Adobe PDF
722.62 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/590354
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 1
social impact